去纤苷(去纤维钠)去哪买的到？

(also called defibrotide sodium) is a polydisperse mixture of single-stranded oligonucleotides. It is not only used to prevent hepatic veno-occlusive disease (VOD), but can also be used to treat hepatic veno-occlusive disease (HVOD). It also has good efficacy, and side effects such as nausea, hypotension, fever and severe bleeding are rare. Today we will learn more about where to buy defibrinoside (defibrinoside)?

Defibrotide has not yet been officially launched in China. Patients in need can purchase the version available abroad. According to Medical Companion Travel, the price of defibrotide is about 22,000. Patients can purchase drugs abroad or obtain drugs through domestic professional overseas medical service organizations (such as Medical Companion Travel), and sign a guarantee contract to guarantee 100% authenticity!

The recommended dose of defibrotide (also called defibrotide sodium) for adult and pediatric patients is 6.25 mg/kg given every 6 hours as a 2-hour intravenous infusion. The dose should be based on the patient's baseline weight, which is defined as the patient's weight before the HSCT preparation protocol. Defibrotide was administered for a minimum of 21 days. If signs and symptoms of hepatic VOD have not resolved after 21 days, continue defibrotide until resolution of VOD or up to a maximum of 60 days. Patients must follow medical advice and use defibrotide under the guidance of a doctor.

Defibrotide was first developed by Gentium Pharmaceuticals in Italy and was approved for marketing in the EU in October 2013. It was approved by the U.S. Food and Drug Administration (FDA) to be launched in the United States on March 30, 2016, under the trade name Defitelio.

Defibrotide is the first drug approved by the U.S. FDA to treat severe hepatic veno-occlusive disease. It is used for adult or pediatric patients with hepatic venous obstruction (VOD) who have undergone blood or bone marrow hematopoietic stem cell transplantation (HSCT) and are accompanied by renal or lung function abnormalities. The drug has also received "orphan drug" designation.

Defibrinoside (also called defibrotide sodium) is a single-chain sodium salt of polydeoxyribose ribonuclease, which has anti-thrombotic, anti-ischemic, anti-inflammatory and fibrinolytic properties. In clinical practice, the drug is mainly used for the treatment of hepatic veno-occlusive disease (HVOD).

The above is the content of the purchase channels for (also called fiber-free sodium), I hope it can help you!